Extracellular vesicles can provide a wealth of information, but these intriguing messengers are notoriously difficult to detect. This could be about to change. Extracellular vesicles (EVs) are a ...
Boehringer Ingelheim has shared more phase 2 data on its kidney disease candidate apecotrep, shedding light on the decision to start a pivotal trial of the prospect last week. The phase 2 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results